Joinn Laboratories(China)Co.,Ltd.

HKSE 6127.HK

Joinn Laboratories(China)Co.,Ltd. Market Capitalization on January 14, 2025: USD 1.45 B

Joinn Laboratories(China)Co.,Ltd. Market Capitalization is USD 1.45 B on January 14, 2025, a -37.89% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.
  • Joinn Laboratories(China)Co.,Ltd. 52-week high Market Capitalization is USD 2.64 B on October 07, 2024, which is 81.73% above the current Market Capitalization.
  • Joinn Laboratories(China)Co.,Ltd. 52-week low Market Capitalization is USD 1.23 B on September 17, 2024, which is -15.44% below the current Market Capitalization.
  • Joinn Laboratories(China)Co.,Ltd. average Market Capitalization for the last 52 weeks is USD 1.65 B.
Key data
Date Market Capitalization Share Price Price to Earnings Ratio (P/E) Price to Sales Ratio (P/S)
Market news
Loading...
HKSE: 6127.HK

Joinn Laboratories(China)Co.,Ltd.

CEO Dr. Yuxia Feng M.D.
IPO Date Feb. 26, 2021
Location China
Headquarters A5 Rongjing East Street
Employees 2,510
Sector Health Care
Industries
Description

Joinn Laboratories(China)Co.,Ltd. provides preclinical and non-clinical services in the United States, the People's Republic of China, and internationally. It operates through three segments: Non-Clinical Studies Services; Clinical Trial and Related Services; and Sales of Research Models. The Non-Clinical Studies Services segment offers drug safety assessment, drug metabolism and pharmacokinetics studies, and pharmacology and efficacy studies. The Clinical Trial and Related Services segment provides clinical CRO services, co-managed phase I clinical research units, and bioanalytical services. The Sales of Research Models segment designs, produces, breeds, and sells research models, non-human primates, and rodents. The company also offers investment management and cell-based assay (CBA) services. Joinn Laboratories(China)Co.,Ltd. was founded in 1995 and is headquartered in Beijing, China.

Similar companies

9995.HK

RemeGen Co., Ltd.

USD 1.59

2.46%

3759.HK

Pharmaron Beijing Co., Ltd.

USD 1.70

5.22%

3347.HK

Hangzhou Tigermed Consulting Co., Ltd.

USD 3.72

2.09%

StockViz Staff

January 15, 2025

Any question? Send us an email